Tumor flare and its prognostic role after discontinuation of treatment with Tyrosine Kinase Inhibitors in patients with metastatic renal cell carcinoma.
Phase of Trial: Phase IV
Latest Information Update: 31 Mar 2016
At a glance
- Drugs Pazopanib (Primary) ; Sunitinib (Primary)
- Indications Renal cell carcinoma
- Focus Therapeutic Use
- 31 Mar 2016 New trial record